Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$931M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$606M |
| 4 |
VMW
VMware, Inc
VMW
|
+$442M |
| 5 |
NVIDIA
NVDA
|
+$427M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$662M |
| 2 |
Home Depot
HD
|
+$354M |
| 3 |
Cigna
CI
|
+$323M |
| 4 |
Valero Energy
VLO
|
+$271M |
| 5 |
Amphenol
APH
|
+$236M |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 15.64% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Watsco
WSO
$15.5B
| $3.96M | ﹤0.01% |
+10,495
| New | +$3.96M |
|
1977
Magnite
MGNI
$3.4B
| $3.96M | ﹤0.01% |
525,321
+481,931
| +1,111% | +$3.63M |
|
1978
Sabre
SABR
$738M
| $3.96M | ﹤0.01% |
881,832
-426,853
| -33% | -$1.92M |
|
1979
Protolabs
PRLB
$1.18B
| $3.95M | ﹤0.01% |
149,593
-66,534
| -31% | -$1.76M |
|
1980
Blackbaud
BLKB
$3.38B
| $3.95M | ﹤0.01% |
56,111
+21,736
| +63% | +$1.53M |
|
1981
X4 Pharmaceuticals
XFOR
$73.2M
| $3.94M | ﹤0.01% |
120,532
-61,188
| -34% | -$2M |
|
1982
Schwab US Large- Cap ETF
SCHX
$60.3B
| $3.94M | ﹤0.01% |
233,622
+109,851
| +89% | +$1.85M |
|
1983
Chart Industries
GTLS
$8.95B
| $3.94M | ﹤0.01% |
+23,299
| New | +$3.94M |
|
|
TRTX
1984
TPG RE Finance Trust
TRTX
$742M
| $3.93M | ﹤0.01% |
583,906
+154,139
| +36% | +$1.04M |
|
1985
Ituran Location and Control
ITRN
$696M
| $3.92M | ﹤0.01% |
131,066
+35,473
| +37% | +$1.06M |
|
1986
Astec Industries
ASTE
$1.06B
| $3.92M | ﹤0.01% |
83,147
+31,606
| +61% | +$1.49M |
|
1987
RXO
RXO
$2.71B
| $3.91M | ﹤0.01% |
+198,351
| New | +$3.91M |
|
1988
Independent Bank
INDB
$3.56B
| $3.9M | ﹤0.01% |
79,473
-40,719
| -34% | -$2M |
|
1989
Prestige Consumer Healthcare
PBH
$3.11B
| $3.9M | ﹤0.01% |
68,149
-22,945
| -25% | -$1.31M |
|
1990
Kimball Electronics
KE
$741M
| $3.9M | ﹤0.01% |
142,280
-138,963
| -49% | -$3.8M |
|
1991
Primerica
PRI
$8.88B
| $3.89M | ﹤0.01% |
20,075
+9,678
| +93% | +$1.88M |
|
1992
Ormat Technologies
ORA
$5.53B
| $3.89M | ﹤0.01% |
55,686
+32,780
| +143% | +$2.29M |
|
1993
Pulmonx
LUNG
$69.3M
| $3.89M | ﹤0.01% |
376,633
-202,438
| -35% | -$2.09M |
|
1994
Aldeyra Therapeutics
ALDX
$324M
| $3.89M | ﹤0.01% |
582,178
+86,603
| +17% | +$579K |
|
1995
Ultragenyx Pharmaceutical
RARE
$2.92B
| $3.88M | ﹤0.01% |
108,948
+53,503
| +96% | +$1.91M |
|
|
PDM
1996
Piedmont Realty Trust, Inc.
PDM
$1.1B
| $3.88M | ﹤0.01% |
691,015
+212,559
| +44% | +$1.19M |
|
1997
Neumora Therapeutics
NMRA
$262M
| $3.88M | ﹤0.01% |
+274,748
| New | +$3.88M |
|
1998
iRadimed
IRMD
$907M
| $3.87M | ﹤0.01% |
87,179
+31,876
| +58% | +$1.41M |
|
|
NWLI
1999
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $3.87M | ﹤0.01% |
+8,835
| New | +$3.87M |
|
2000
UroGen Pharma
URGN
$869M
| $3.86M | ﹤0.01% |
275,785
+83,657
| +44% | +$1.17M |
|